Study of hepatitis B virus infection, reactivation among patients with chronic hepatitis C infection treated by direct antiviral agents (DAAs)

Egyptian Liver Journal

Table 1 Comparison between HCV RNA PCR results in the studied patients

N = 200		At the start of treatment		After 1 month of treatment		At the end of treatment		P-value
HCV RNA PCR	Negative	0	0%	190	95%	196	98%	P1 < 0.001 HS P2 = 0.04 S P3 < 0.001 HS
HCV RNA PCR	Positive	200	100%	10	5%	4	2%	P1 < 0.001 HS P2 = 0.04 S P3 < 0.001 HS

X²: chi-square test
S: p-value < 0.05 is considered significant
HS: p-value < 0.001 is considered highly significant
P1: refers to the statistical difference between the start of DAA and 1 month after DAA
P2: refers to the statistical difference between the start of DAA and at the end of DAA
P3: refers to the statistical difference between 1 month after DAA and at the end of DAA